Linical's Growth Strategy

Linical's Growth Strategy

Positioning innovative drug development support as a new pillar of business

Linical has offices in Japan and other parts of Asia, the United States, and Europe to support global development strategies for pharmaceutical companies. Our locations in each country are staffed with personnel who are thoroughly familiar with the drug development situation, and we have established an environment enabling communication based on Japanese language.
In particular, in global clinical trials for difficult areas such as oncology and the central nervous system, early development stages are conducted in Japan with Linical serving as a contact point, and then development is expanded to offices in Japan and other parts of Asia. Late stages of development are conducted in Japan/Asia, the United States and Europe with the aim of simultaneous release of new drugs.

Establishment of a Global Organization is Progressing
(As of March 31, 2020)

Global
  • Establish the structure of 1,000 employees
Japan
  • ① Strengthen regenerative medical field in addition to Oncology, CNS and Immunology
  • ② Advance to dermatology, ophthalmic field
  • ③ Consider establishment of Linical Australia and Linical South Africa
Asia
  • (Korea)
  • ① Expand the structure to 100 employees
  • ② Establish a high profitable constitution based on the surplus of two consecutive years
  • (Taiwan)
  • ① Acquisition of new orders also including Singaporean subsidiary
  • ② Consider advance into Hong Kong, Philippines
  • (China)
  • ① Advance to China(Completed establishment of a subsidiary in Shanghai)
  • ② Temporary staffing from Japan
Europe
  • ① Aim to improve the profit ratio by enhancing it’s competitiveness
  • ② Consider establishment of Linical Italy / Strengthen recruitment of CRA in UK / Examine increase the number of staff and office.
  • ③ Accelerate integration of Linical Accelovance Europe and Linical Europe
USA
  • ① Develop as a center of business
  • ② Consider establishment of Linical Canada
  • ③ Consider advance into Latin America